These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36300716)

  • 1. Efficacy of antiseizure medication in a mouse model of HCN1 developmental and epileptic encephalopathy.
    Bleakley LE; McKenzie CE; Reid CA
    Epilepsia; 2023 Jan; 64(1):e1-e8. PubMed ID: 36300716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cation leak underlies neuronal excitability in an HCN1 developmental and epileptic encephalopathy.
    Bleakley LE; McKenzie CE; Soh MS; Forster IC; Pinares-Garcia P; Sedo A; Kathirvel A; Churilov L; Jancovski N; Maljevic S; Berkovic SF; Scheffer IE; Petrou S; Santoro B; Reid CA
    Brain; 2021 Aug; 144(7):2060-2073. PubMed ID: 33822003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seizures, behavioral deficits, and adverse drug responses in two new genetic mouse models of
    Merseburg A; Kasemir J; Buss EW; Leroy F; Bock T; Porro A; Barnett A; Tröder SE; Engeland B; Stockebrand M; Moroni A; Siegelbaum SA; Isbrandt D; Santoro B
    Elife; 2022 Aug; 11():. PubMed ID: 35972069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinal Dysfunction in a Mouse Model of HCN1 Genetic Epilepsy.
    Zhao D; Pinares-Garcia P; McKenzie CE; Bleakley LE; Forster IC; Wong VHY; Nguyen CTO; Scheffer IE; Reid CA; Bui BV
    J Neurosci; 2023 Mar; 43(12):2199-2209. PubMed ID: 36813574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
    Nevitt SJ; Sudell M; Weston J; Tudur Smith C; Marson AG
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011412. PubMed ID: 28661008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HCN1 mutation spectrum: from neonatal epileptic encephalopathy to benign generalized epilepsy and beyond.
    Marini C; Porro A; Rastetter A; Dalle C; Rivolta I; Bauer D; Oegema R; Nava C; Parrini E; Mei D; Mercer C; Dhamija R; Chambers C; Coubes C; Thévenon J; Kuentz P; Julia S; Pasquier L; Dubourg C; Carré W; Rosati A; Melani F; Pisano T; Giardino M; Innes AM; Alembik Y; Scheidecker S; Santos M; Figueiroa S; Garrido C; Fusco C; Frattini D; Spagnoli C; Binda A; Granata T; Ragona F; Freri E; Franceschetti S; Canafoglia L; Castellotti B; Gellera C; Milanesi R; Mancardi MM; Clark DR; Kok F; Helbig KL; Ichikawa S; Sadler L; Neupauerová J; Laššuthova P; Šterbová K; Laridon A; Brilstra E; Koeleman B; Lemke JR; Zara F; Striano P; Soblet J; Smits G; Deconinck N; Barbuti A; DiFrancesco D; LeGuern E; Guerrini R; Santoro B; Hamacher K; Thiel G; Moroni A; DiFrancesco JC; Depienne C
    Brain; 2018 Nov; 141(11):3160-3178. PubMed ID: 30351409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HCN1 pathogenic variants associated with childhood epilepsy in a cohort of Chinese patients.
    Yang Z; Kuang Z; Liao H; Gan S; Peng X; Yang H; Wu L
    Epileptic Disord; 2024 Feb; 26(1):90-97. PubMed ID: 38009841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy of antiepileptic drugs for patients with generalized epileptic seizures: systematic review and network meta-analyses.
    Campos MSA; Ayres LR; Morelo MRS; Carizio FAM; Pereira LRL
    Int J Clin Pharm; 2018 Jun; 40(3):589-598. PubMed ID: 29744790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel de novo HCN2 loss-of-function variant causing developmental and epileptic encephalopathy treated with a ketogenic diet.
    DiFrancesco JC; Ragona F; Murano C; Frosio A; Melgari D; Binda A; Calamaio S; Prevostini R; Mauri M; Canafoglia L; Castellotti B; Messina G; Gellera C; Previtali R; Veggiotti P; Milanesi R; Barbuti A; Solazzi R; Freri E; Granata T; Rivolta I
    Epilepsia; 2023 Dec; 64(12):e222-e228. PubMed ID: 37746765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case-control pharmacogenetic study of HCN1/HCN2 variants and genetic generalized epilepsies.
    Wu SZ; Ye H; Yang XG; Lu ZL; Qu Q; Qu J
    Clin Exp Pharmacol Physiol; 2018 Mar; 45(3):226-233. PubMed ID: 29047147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
    Brigo F; Igwe SC; Lattanzi S
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD003032. PubMed ID: 33475151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
    Brigo F; Igwe SC; Lattanzi S
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD003032. PubMed ID: 30734919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel de novo HCN1 loss-of-function mutation in genetic generalized epilepsy causing increased neuronal excitability.
    Bonzanni M; DiFrancesco JC; Milanesi R; Campostrini G; Castellotti B; Bucchi A; Baruscotti M; Ferrarese C; Franceschetti S; Canafoglia L; Ragona F; Freri E; Labate A; Gambardella A; Costa C; Rivolta I; Gellera C; Granata T; Barbuti A; DiFrancesco D
    Neurobiol Dis; 2018 Oct; 118():55-63. PubMed ID: 29936235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biophysical analysis of an HCN1 epilepsy variant suggests a critical role for S5 helix Met-305 in voltage sensor to pore domain coupling.
    Hung A; Forster IC; Mckenzie CE; Berecki G; Petrou S; Kathirvel A; Soh MS; Reid CA
    Prog Biophys Mol Biol; 2021 Nov; 166():156-172. PubMed ID: 34298002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium valproate versus phenytoin monotherapy for epilepsy: an individual participant data review.
    Nevitt SJ; Marson AG; Weston J; Tudur Smith C
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD001769. PubMed ID: 30091458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the pentylenetetrazole seizure threshold test in epileptic mice as surrogate model for drug testing against pharmacoresistant seizures.
    Töllner K; Twele F; Löscher W
    Epilepsy Behav; 2016 Apr; 57(Pt A):95-104. PubMed ID: 26930359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A reappraisal of atypical absence seizures in children and adults: therapeutic implications.
    Brigo F; Striano P; Belcastro V
    Expert Opin Pharmacother; 2019 Dec; 20(17):2115-2120. PubMed ID: 31446808
    [No Abstract]   [Full Text] [Related]  

  • 18. Trends in antiseizure medication prescription patterns among all adults, women, and older adults with epilepsy: A German longitudinal analysis from 2008 to 2020.
    Hochbaum M; Kienitz R; Rosenow F; Schulz J; Habermehl L; Langenbruch L; Kovac S; Knake S; von Podewils F; von Brauchitsch S; Hamacher M; Strzelczyk A; Willems LM
    Epilepsy Behav; 2022 May; 130():108666. PubMed ID: 35339390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
    Brigo F; Igwe SC
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD003032. PubMed ID: 28195639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of action of currently used antiseizure drugs.
    Sills GJ; Rogawski MA
    Neuropharmacology; 2020 May; 168():107966. PubMed ID: 32120063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.